nach oben

Current Osteoporosis Reports

Erschienen in:

05.08.2023

Osteoporosis and Fracture Risk among Older US Asian Adults

verfasst von: Joan C. Lo, Wei Yang, Jennifer J. Park-Sigal, Susan M. Ott

Erschienen in: Current Osteoporosis Reports | Ausgabe 5/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

This review summarizes the current knowledge regarding osteoporosis and fracture among older US Asian adults.

Recent Findings

Asian adults have lower (areal) bone density than non-Hispanic White adults and thus are more likely to be diagnosed and treated for osteoporosis, despite their lower risk of hip fracture. The latter may relate to favorable characteristics in hip geometry, volumetric bone density, and bone microarchitecture; lower risk of falls; and other clinical factors. The fracture risk calculator FRAX accounts for the lower risk of hip fracture among US Asian adults. However, data on major osteoporotic fracture risk remain limited. Fracture rates also vary by Asian subgroup, which may have implications for fracture risk assessment. Furthermore, among women receiving bisphosphonate drugs, Asian race is a risk factor for atypical femur fracture, an uncommon complication associated with treatment duration. Recent clinical trial efficacy data pertaining to lower bisphosphonate doses and longer dosing intervals may be relevant for Asian adults.

Summary

More research is needed to inform osteoporosis care of US Asian adults, including risk-benefit considerations and the optimal duration of bisphosphonate treatment. Greater evidence-based guidance for primary fracture prevention among US Asian adults will ensure health equity in the prevention of osteoporotic fractures.

Budiman A, Ruiz NG. Key facts about Asian Americans, a diverse and growing population. Washington: Pew Research Institute; 2021. https://www.pewresearch.org/fact-tank/2021/04/29/key-facts-about-asian-americans/. Accessed 25 May 2023.

Budiman A, Ruiz NG. Asian Americans are the fastest-growing racial or ethnic group in the U.S. Washington: Pew Research Institute; 2021. https://www.pewresearch.org/fact-tank/2021/04/09/asian-americans-are-the-fastest-growing-racial-or-ethnic-group-in-the-u-s/. Accessed 25 May 2023.

Carlson AW. One century of foreign immigration to the United States: 1880–1979. Int Migr. 1985;23(3):309–34. https://doi.org/10.1111/j.1468-2435.1985.tb00322.x.CrossRefPubMed

Zong J, Batalova J. Frequently requested statistics on immigrants and immigration in the United States. Migration Immigration Source. Washington: Migration Policy Institute; 2017. http://www.migrationpolicy.org/print/15856#.WPJLepqgu5s. Accessed 25 May 2023.

Largest U.S. Immigrant Groups over Time, 1960-Present. Migration Policy Institute, Washington, DC. https://www.migrationpolicy.org/programs/data-hub/charts/largest-immigrant-groups-over-time. Accessed 25 May 2023.

Asian American and Pacific Islander Heritage Month: May 2022. Press Release Number CB22-FF05: April 18, 2022. United States Census Bureau. https://www.census.gov/newsroom/facts-for-features/2022/asian-american-pacific-islander.html. Accessed 25 May 2023.

United States Census Bureau. https://www.census.gov/. Accessed 25 May 2023.

Vespa J, Medina L, Armstrong DM. Demographic Turning Points for the United States: Population Projections for 2020 to 2060. Current Population Reports. P25–1144. Issued March 2018, revised February 2020. United States Census Bureau. https://www.census.gov/content/dam/Census/library/publications/2020/demo/p25-1144.pdf. Accessed 25 May 2023.

Hoeffel EM, Rastogi S, Kim MO, Shahid H. The Asian Population: 2010. 2010 Census Briefs. Issued March 2012. United States Census Bureau. https://www2.census.gov/library/publications/cen2010/briefs/c2010br-11.pdf. Accessed 25 May 2023.

10.

Johnson H, McGhee E, Mejia MC. California’s Population. Fact Sheet January 2023: Public Policy Institute of California. https://www.ppic.org/publication/californias-population/. Accessed 25 May 2023.

11.

•• Noel SE, Santos MP, Wright NC. Racial and ethnic disparities in bone health and outcomes in the United States. J Bone Miner Res. 2021;36(10):1881–905. https://doi.org/10.1002/jbmr.4417. This important and comprehensive review paper summarizes racial and ethnic differences in bone density, fracture, and osteoporosis care that can inform efforts to address bone health disparities.CrossRefPubMed

12.

Lo JC, Ettinger B. How should we counsel Asian Americans about fracture risk? J Am Geriatr Soc. 2020;68(7):1613–6. https://doi.org/10.1111/jgs.16444.CrossRefPubMed

13.

What Census Calls Us. Pew Research Institute, Washington, DC. February 6, 2020. https://www.pewsocialtrends.org/interactives/multiracial-timeline/. Accessed 25 May 2023.

14.

Jain RK, Vokes T. Dual-energy X-ray absorptiometry. J Clin Densitom. 2017;20(3):291–303. https://doi.org/10.1016/j.jocd.2017.06.014.CrossRefPubMed

15.

•• Lo JC, Hui RL, Grimsrud CD, Chandra M, Neugebauer RS, Gonzalez JR, et al. The association of race/ethnicity and risk of atypical femur fracture among older women receiving oral bisphosphonate therapy. Bone. 2016;85:142–7. https://doi.org/10.1016/j.bone.2016.01.002. This study was the first to quantify the increased risk of atypical femur fracture among Asian compared to White women who received bisphosphonate drugs. An association of AFF and Asian race was first reported by references #28 and #115 in 2012.

16.

Wysowski DK, Greene P. Trends in osteoporosis treatment with oral and intravenous bisphosphonates in the United States, 2002–2012. Bone. 2013;57(2):423–8. https://doi.org/10.1016/j.bone.2013.09.008.CrossRefPubMed

17.

Lauderdale DS, Jacobsen SJ, Furner SE, Levy PS, Brody JA, Goldberg J. Hip fracture incidence among elderly Asian-American populations. Am J Epidemiol. 1997;146(6):502–9. https://doi.org/10.1093/oxfordjournals.aje.a009304.CrossRefPubMed

18.

Wright NC, Saag KG, Curtis JR, Smith WK, Kilgore ML, Morrisey MA, et al. Recent trends in hip fracture rates by race/ethnicity among older US adults. J Bone Miner Res. 2012;27(11):2325–32. https://doi.org/10.1002/jbmr.1684.CrossRefPubMed

19.

Taylor AJ, Gary LC, Arora T, Becker DJ, Curtis JR, Kilgore ML, et al. Clinical and demographic factors associated with fractures among older Americans. Osteoporos Int. 2011;22(4):1263–74. https://doi.org/10.1007/s00198-010-1300-8.CrossRefPubMed

20.

• Lo JC, Chandra M, Lee DR, Darbinian JA, Gordon NP, Zeltser DW, et al. Sex- and ethnic-specific patterns in the incidence of hip fracture among older US Asian and non-Hispanic White adults. J Am Geriatr Soc. 2023. https://doi.org/10.1111/jgs.18242. This contemporary study describes hip fracture incidence among major US Asian subgroups by sex, including Chinese, Filipino, South Asian, and Japanese adults compared to White adults.

21.

Sullivan KJ, Husak LE, Altebarmakian M, Brox WT. Demographic factors in hip fracture incidence and mortality rates in California, 2000–2011. J Orthop Surg Res. 2016;11(1):4. https://doi.org/10.1186/s13018-015-0332-3.CrossRefPubMedPubMedCentral

22.

Cong E, Walker MD. The Chinese skeleton: insights into microstructure that help to explain the epidemiology of fracture. Bone Res. 2014;2:14009. https://doi.org/10.1038/boneres.2014.9.CrossRefPubMedPubMedCentral

23.

Zengin A, Prentice A, Ward KA. Ethnic differences in bone health. Front Endocrinol (Lausanne). 2015;6:24. https://doi.org/10.3389/fendo.2015.00024.CrossRefPubMed

24.

• Durdin R, Parsons CM, Dennison E, Harvey NC, Cooper C, Ward K. Ethnic differences in bone microarchitecture. Curr Osteoporos Rep. 2020;18(6):803–10. https://doi.org/10.1007/s11914-020-00642-y. This recent review summarizes ethnic differences in bone microarchitecture, focusing in particular on studies that use peripheral quantitative computed tomography imaging techniques.CrossRefPubMedPubMedCentral

25.

Nguyen HH, Lakhani A, Shore-Lorenti C, Zebaze R, Vincent AJ, Milat F, et al. Asian ethnicity is associated with atypical femur fractures in an Australian population study. Bone. 2020;135:115319. https://doi.org/10.1016/j.bone.2020.115319.CrossRefPubMed

26.

Black DM, Condra K, Adams AL, Eastell R. Bisphosphonates and the risk of atypical femur fractures. Bone. 2022;156:116297. https://doi.org/10.1016/j.bone.2021.116297.CrossRefPubMed

27.

•• Black DM, Geiger EJ, Eastell R, Vittinghoff E, Li BH, Ryan DS, et al. Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates. N Engl J Med. 2020;383(8):743–53. https://doi.org/10.1056/NEJMoa1916525. This study reports the association of bisphophonate treatment duration and the risk of atypical femur fracture, the increased risk associated with Asian race, and risk reduction after treatment cessation. The authors also provide estimated risk-benefit projections.CrossRefPubMedPubMedCentral

28.

Lo JC, Huang SY, Lee GA, Khandelwal S, Provus J, Ettinger B, et al. Clinical correlates of atypical femoral fracture. Bone. 2012;51(1):181–4. https://doi.org/10.1016/j.bone.2012.02.632.CrossRefPubMed

29.

Neviaser AS, Lane JM, Lenart BA, Edobor-Osula F, Lorich DG. Low-energy femoral shaft fractures associated with alendronate use. J Orthop Trauma. 2008;22(5):346–50. https://doi.org/10.1097/BOT.0b013e318172841c.CrossRefPubMed

30.

Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CY. Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab. 2005;90(3):1294–301. https://doi.org/10.1210/jc.2004-0952.CrossRefPubMed

31.

Lenart BA, Lorich DG, Lane JM. Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate. N Engl J Med. 2008;358(12):1304–6. https://doi.org/10.1056/NEJMc0707493.CrossRefPubMed

32.

Goh SK, Yang KY, Koh JS, Wong MK, Chua SY, Chua DT, et al. Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution. J Bone Joint Surg Br. 2007;89(3):349–53. https://doi.org/10.1302/0301-620X.89B3.18146.CrossRefPubMed

33.

Kwek EB, Goh SK, Koh JS, Png MA, Howe TS. An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy? Injury. 2008;39(2):224–31. https://doi.org/10.1016/j.injury.2007.08.036.CrossRefPubMed

34.

Ammann P, Rizzoli R. Bone strength and its determinants. Osteoporos Int. 2003;14(Suppl 3):S13–8. https://doi.org/10.1007/s00198-002-1345-4.CrossRefPubMed

35.

Marshall LM, Zmuda JM, Chan BK, Barrett-Connor E, Cauley JA, Ensrud KE, et al. Race and ethnic variation in proximal femur structure and BMD among older men. J Bone Miner Res. 2008;23(1):121–30. https://doi.org/10.1359/jbmr.070908.CrossRefPubMed

36.

Finkelstein JS, Lee ML, Sowers M, Ettinger B, Neer RM, Kelsey JL, et al. Ethnic variation in bone density in premenopausal and early perimenopausal women: effects of anthropometric and lifestyle factors. J Clin Endocrinol Metab. 2002;87(7):3057–67. https://doi.org/10.1210/jcem.87.7.8654.CrossRefPubMed

37.

Marquez MA, Melton LJ 3rd, Muhs JM, Crowson CS, Tosomeen A, O’Connor MK, et al. Bone density in an immigrant population from Southeast Asia. Osteoporos Int. 2001;12(7):595–604. https://doi.org/10.1007/s001980170083.CrossRefPubMed

38.

Khandelwal S, Chandra M, Lo JC. Clinical characteristics, bone mineral density and non-vertebral osteoporotic fracture outcomes among post-menopausal U.S. South Asian women. Bone. 2012;51(6):1025–8. https://doi.org/10.1016/j.bone.2012.08.118.CrossRefPubMed

39.

Lo JC, Chandra M, Lee C, Darbinian JA, Ramaswamy M, Ettinger B. Bone mineral density in older U.S. Filipino, Chinese, Japanese, and White women. J Am Geriatr Soc. 2020;68(11):2656–61. https://doi.org/10.1111/jgs.16785.CrossRefPubMed

40.

Ross PD, Norimatsu H, Davis JW, Yano K, Wasnich RD, Fujiwara S, et al. A comparison of hip fracture incidence among native Japanese, Japanese Americans, and American Caucasians. Am J Epidemiol. 1991;133(8):801–9. https://doi.org/10.1093/oxfordjournals.aje.a115959.CrossRefPubMed

41.

Kin K, Lee JH, Kushida K, Sartoris DJ, Ohmura A, Clopton PL, et al. Bone density and body composition on the Pacific Rim: a comparison between Japan-born and U.S.-born Japanese-American women. J Bone Miner Res. 1993;8(7):861–9. https://doi.org/10.1002/jbmr.5650080712.CrossRefPubMed

42.

Morton DJ, Barrett-Connor E, Kritz-Silverstein D, Wingard DL, Schneider DL. Bone mineral density in postmenopausal Caucasian, Filipina, and Hispanic women. Int J Epidemiol. 2003;32(1):150–6. https://doi.org/10.1093/ije/dyg024.CrossRefPubMed

43.

Walker MD, Babbar R, Opotowsky AR, Rohira A, Nabizadeh F, Badia MD, et al. A referent bone mineral density database for Chinese American women. Osteoporos Int. 2006;17(6):878–87. https://doi.org/10.1007/s00198-005-0059-9.CrossRefPubMed

44.

Melamed A, Vittinghoff E, Sriram U, Schwartz AV, Kanaya AM. BMD reference standards among South Asians in the United States. J Clin Densitom. 2010;13(4):379–84. https://doi.org/10.1016/j.jocd.2010.05.007.CrossRefPubMedPubMedCentral

45.

Finkelstein JS, Brockwell SE, Mehta V, Greendale GA, Sowers MR, Ettinger B, et al. Bone mineral density changes during the menopause transition in a multiethnic cohort of women. J Clin Endocrinol Metab. 2008;93(3):861–8. https://doi.org/10.1210/jc.2007-1876.CrossRefPubMed

46.

Shieh A, Ruppert KM, Greendale GA, Lian Y, Cauley JA, Burnett-Bowie SA, et al. Associations of age at menopause with postmenopausal bone mineral density and fracture risk in women. J Clin Endocrinol Metab. 2022;107(2):e561–9. https://doi.org/10.1210/clinem/dgab690.CrossRefPubMed

47.

Lo JC, Kim S, Chandra M, Ettinger B. Applying ethnic-specific bone mineral density T-scores to Chinese women in the USA. Osteoporos Int. 2016;27(12):3477–84. https://doi.org/10.1007/s00198-016-3673-9.CrossRefPubMed

48.

• Lo JC, Lee DR, Chandra M, Zeltser DW, Chu CE, Gordon NP, et al. Differences in proximal humerus and wrist fracture incidence among US Asian subgroups. J Am Geriatr Soc. 2023. https://doi.org/10.1111/jgs.18408. This contemporary study describes proximal humerus and wrist fracture incidence among major US Asian subgroups by sex, including Chinese, Filipino, South Asian, and Japanese adults compared to White adults.

49.

Faulkner KG. The tale of the T-score: review and perspective. Osteoporos Int. 2005;16(4):347–52. https://doi.org/10.1007/s00198-004-1779-y.CrossRefPubMed

50.

Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res. 1994;9(8):1137–41. https://doi.org/10.1002/jbmr.5650090802.CrossRefPubMed

51.

Binkley NC, Schmeer P, Wasnich RD, Lenchik L, International Society for Clinical Densitometry Position Development P, Scientific Advisory C. What are the criteria by which a densitometric diagnosis of osteoporosis can be made in males and non-Caucasians? J Clin Densitom. 2002;5 Suppl:S19-27. https://doi.org/10.1385/jcd:5:3s:s19.CrossRefPubMed

52.

Bonnick SL. Bone Densitometry in Clinical Practice. 3rd ed. New York: Humana Press; 2010.CrossRef

53.

Chen Z, Maricic M, Lund P, Tesser J, Gluck O. How the new Hologic hip normal reference values affect the densitometric diagnosis of osteoporosis. Osteoporos Int. 1998;8(5):423–7. https://doi.org/10.1007/s001980050086.CrossRefPubMed

54.

Looker AC, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP, et al. Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int. 1998;8(5):468–89. https://doi.org/10.1007/s001980050093.CrossRefPubMed

55.

Looker AC, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP, et al. Proximal femur bone mineral levels of US adults. Osteoporos Int. 1995;5(5):389–409. https://doi.org/10.1007/BF01622262.CrossRefPubMed

56.

Binkley N, Bilezikian JP, Kendler DL, Leib ES, Lewiecki EM, Petak SM, et al. Official positions of the International Society for Clinical Densitometry and Executive Summary of the 2005 Position Development Conference. J Clin Densitom. 2006;9(1):4–14. https://doi.org/10.1016/j.jocd.2006.05.002.CrossRefPubMed

57.

Schousboe JT, Shepherd JA, Bilezikian JP, Baim S. Executive summary of the 2013 International Society for Clinical Densitometry Position Development Conference on bone densitometry. J Clin Densitom. 2013;16(4):455–66. https://doi.org/10.1016/j.jocd.2013.08.004.CrossRefPubMed

58.

2019 ISCD Official Positions: Adult. International Society for Clinical Densitometry. 2019. https://iscd.org/learn/official-positions/adult-positions/. Accessed 25 May 2023.

59.

LeBoff MS, Greenspan SL, Insogna KL, Lewiecki EM, Saag KG, Singer AJ, et al. The clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int. 2022;33(10):2049–102. https://doi.org/10.1007/s00198-021-05900-y.CrossRefPubMedPubMedCentral

60.

Kanis JA, McCloskey EV, Johansson H, Oden A, Melton LJ 3rd, Khaltaev N. A reference standard for the description of osteoporosis. Bone. 2008;42(3):467–75. https://doi.org/10.1016/j.bone.2007.11.001.CrossRefPubMed

61.

Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med. 1995;332(12):767–73. https://doi.org/10.1056/NEJM199503233321202.CrossRefPubMed

62.

Siris ES, Miller PD, Barrett-Connor E, Faulkner KG, Wehren LE, Abbott TA, et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA. 2001;286(22):2815–22. https://doi.org/10.1001/jama.286.22.2815.CrossRefPubMed

63.

Barrett-Connor E, Siris ES, Wehren LE, Miller PD, Abbott TA, Berger ML, et al. Osteoporosis and fracture risk in women of different ethnic groups. J Bone Miner Res. 2005;20(2):185–94. https://doi.org/10.1359/JBMR.041007.CrossRefPubMed

64.

Felsenberg D, Boonen S. The bone quality framework: determinants of bone strength and their interrelationships, and implications for osteoporosis management. Clin Ther. 2005;27(1):1–11. https://doi.org/10.1016/j.clinthera.2004.12.020.CrossRefPubMed

65.

Walker MD, McMahon DJ, Udesky J, Liu G, Bilezikian JP. Application of high-resolution skeletal imaging to measurements of volumetric BMD and skeletal microarchitecture in Chinese-American and white women: explanation of a paradox. J Bone Miner Res. 2009;24(12):1953–9. https://doi.org/10.1359/jbmr.090528.CrossRefPubMedPubMedCentral

66.

Liu XS, Walker MD, McMahon DJ, Udesky J, Liu G, Bilezikian JP, et al. Better skeletal microstructure confers greater mechanical advantages in Chinese-American women versus white women. J Bone Miner Res. 2011;26(8):1783–92. https://doi.org/10.1002/jbmr.378.CrossRefPubMed

67.

Walker MD, Liu XS, Stein E, Zhou B, Bezati E, McMahon DJ, et al. Differences in bone microarchitecture between postmenopausal Chinese-American and white women. J Bone Miner Res. 2011;26(7):1392–8. https://doi.org/10.1002/jbmr.352.CrossRefPubMed

68.

Silva BC, Leslie WD, Resch H, Lamy O, Lesnyak O, Binkley N, et al. Trabecular bone score: a noninvasive analytical method based upon the DXA image. J Bone Miner Res. 2014;29(3):518–30. https://doi.org/10.1002/jbmr.2176.CrossRefPubMed

69.

Silva BC, Walker MD, Abraham A, Boutroy S, Zhang C, McMahon DJ, et al. Trabecular bone score is associated with volumetric bone density and microarchitecture as assessed by central QCT and HRpQCT in Chinese American and white women. J Clin Densitom. 2013;16(4):554–61. https://doi.org/10.1016/j.jocd.2013.07.001.CrossRefPubMed

70.

Leslie WD, Aubry-Rozier B, Lamy O, Hans D, Manitoba Bone Density P. TBS (trabecular bone score) and diabetes-related fracture risk. J Clin Endocrinol Metab. 2013;98(2):602–9. https://doi.org/10.1210/jc.2012-3118.CrossRefPubMed

71.

Cheng YJ, Kanaya AM, Araneta MRG, Saydah SH, Kahn HS, Gregg EW, et al. Prevalence of diabetes by race and ethnicity in the United States, 2011–2016. JAMA. 2019;322(24):2389–98. https://doi.org/10.1001/jama.2019.19365.CrossRefPubMedPubMedCentral

72.

Looker AC, Sarafrazi Isfahani N, Fan B, Shepherd JA. Trabecular bone scores and lumbar spine bone mineral density of US adults: comparison of relationships with demographic and body size variables. Osteoporos Int. 2016;27(8):2467–75. https://doi.org/10.1007/s00198-016-3550-6.CrossRefPubMedPubMedCentral

73.

Jain RK, Vokes TJ. African Americans have lower TBS than whites among densitometry patients at a Chicago academic center. Osteoporos Int. 2017;28(3):917–23. https://doi.org/10.1007/s00198-016-3796-z.CrossRefPubMed

74.

• Cauley JA, Karlamangla AS, Ruppert K, Lian Y, Huang M, Harlow S, et al. Race/ethnic difference in trabecular bone score in midlife women: The Study of Women’s Health Across the Nation (SWAN). Arch Osteoporos. 2021;16(1):91. https://doi.org/10.1007/s11657-021-00951-4. This report from the Study of Women’s Health Across the Nation found that trabecular bone score was similar in Black and White women after accounting for tissue thickness and covariates, whereas Japanese women had modestly lower trabecular bone score.CrossRefPubMedPubMedCentral

75.

Jain RK, Vokes T. Association of trabecular bone score (TBS) and prior fracture differs among minorities in NHANES 2005–2008. Osteoporos Int. 2018;29(9):2093–9. https://doi.org/10.1007/s00198-018-4584-8.CrossRefPubMed

76.

Faulkner KG, Cummings SR, Black D, Palermo L, Gluer CC, Genant HK. Simple measurement of femoral geometry predicts hip fracture: the Study of Osteoporotic Fractures. J Bone Miner Res. 1993;8(10):1211–7. https://doi.org/10.1002/jbmr.5650081008.CrossRefPubMed

77.

Cummings SR, Cauley JA, Palermo L, Ross PD, Wasnich RD, Black D, et al. Racial differences in hip axis lengths might explain racial differences in rates of hip fracture. Study of Osteoporotic Fractures Research Group. Osteoporos Int. 1994;4(4):226–9. https://doi.org/10.1007/BF01623243.CrossRefPubMed

78.

Brownbill RA, Ilich JZ. Hip geometry and its role in fracture: what do we know so far? Curr Osteoporos Rep. 2003;1(1):25–31. https://doi.org/10.1007/s11914-003-0005-8.CrossRefPubMed

79.

Danielson ME, Beck TJ, Lian Y, Karlamangla AS, Greendale GA, Ruppert K, et al. Ethnic variability in bone geometry as assessed by hip structure analysis: findings from the hip strength across the menopausal transition study. J Bone Miner Res. 2013;28(4):771–9. https://doi.org/10.1002/jbmr.1781.CrossRefPubMed

80.

Ishii S, Cauley JA, Greendale GA, Danielson ME, Safaei Nili N, Karlamangla A. Ethnic differences in composite indices of femoral neck strength. Osteoporos Int. 2012;23(4):1381–90. https://doi.org/10.1007/s00198-011-1723-x.CrossRefPubMed

81.

Nagaraj N, Boudreau RM, Danielson ME, Greendale GA, Karlamangla AS, Beck TJ, et al. Longitudinal changes in hip geometry in relation to the final menstrual period: Study of Women’s Health Across the Nation (SWAN). Bone. 2019;122:237–45. https://doi.org/10.1016/j.bone.2019.02.016.CrossRefPubMedPubMedCentral

82.

• Hsu S, Hoofnagle AN, Gupta DK, Gutierrez OM, Peralta CA, Shea S, et al. Race, ancestry, and vitamin D metabolism: the Multi-Ethnic Study of Atherosclerosis. J Clin Endocrinol Metab. 2020;105(12):e4337-50. https://doi.org/10.1210/clinem/dgaa612. This report from the Multi-Ethnic Study of Atherosclerosis examines racial and ethnic differences in vitamin D metabolism measures, including White, Black, Chinese, and Hispanic adults and relationship with ancestry.CrossRefPubMedPubMedCentral

83.

Oshiro CE, Hillier TA, Edmonds G, Peterson M, Hill PL, Hampson S. Vitamin D deficiency and insufficiency in Hawaii: Levels and sources of serum vitamin D in older adults. Am J Hum Biol. 2021;e23636. https://doi.org/10.1002/ajhb.23636.

84.

Gordon NP, Caan BJ, Asgari MM. Variation in vitamin D supplementation among adults in a multi-race/ethnic health plan population, 2008. Nutr J. 2012;11:104. https://doi.org/10.1186/1475-2891-11-104.CrossRefPubMedPubMedCentral

85.

Darling AL. Vitamin D deficiency in western dwelling South Asian populations: an unrecognised epidemic. Proc Nutr Soc. 2020;79(3):259–71. https://doi.org/10.1017/S0029665120000063.CrossRefPubMedPubMedCentral

86.

Herrick KA, Storandt RJ, Afful J, Pfeiffer CM, Schleicher RL, Gahche JJ, et al. Vitamin D status in the United States, 2011–2014. Am J Clin Nutr. 2019;110(1):150–7. https://doi.org/10.1093/ajcn/nqz037.CrossRefPubMedPubMedCentral

87.

Ho SB, Li CF, Chandra M, Lo JC. Vitamin D status among women of different Asian subgroups initiating osteoporosis therapy J Asian. Health. 2023;3(1):February. https://doi.org/10.59448/jah.v3i1.30.CrossRef

88.

Li CF, Ettinger B, Chandra M, Lo JC. Vitamin D status among older women initiating osteoporosis therapy. J Am Geriatr Soc. 2019;67(10):2207–8. https://doi.org/10.1111/jgs.16133.CrossRefPubMedPubMedCentral

89.

Stratton-Loeffler MJ, Lo JC, Hui RL, Coates A, Minkoff JR, Budayr A. Treatment of vitamin D deficiency within a large integrated health care delivery system. J Manag Care Pharm. 2012;18(7):497–505. https://doi.org/10.18553/jmcp.2012.18.7.497.CrossRefPubMed

90.

LeBoff MS, Chou SH, Ratliff KA, Cook NR, Khurana B, Kim E, et al. Supplemental vitamin D and incident fractures in midlife and older adults. N Engl J Med. 2022;387(4):299–309. https://doi.org/10.1056/NEJMoa2202106.CrossRefPubMedPubMedCentral

91.

Balk EM, Adam GP, Langberg VN, Earley A, Clark P, Ebeling PR, et al. Global dietary calcium intake among adults: a systematic review. Osteoporos Int. 2017;28(12):3315–24. https://doi.org/10.1007/s00198-017-4230-x.CrossRefPubMedPubMedCentral

92.

• Ali SH, Yi SS, Kranick J, Lee M, Thorpe LE, Rummo PE. Disentangling the roles of generational status and acculturation on dietary behaviors in disaggregated Asian American subgroups. Appetite. 2022;171:105903. https://doi.org/10.1016/j.appet.2021.105903. This paper examines the association of generational status and acculturation in a surveyed cohort of 3018 Asian American adults and includes findings among disaggregated Asian subgroups.CrossRefPubMedPubMedCentral

93.

Dai Z, Wang R, Ang LW, Yuan JM, Koh WP. Bone turnover biomarkers and risk of osteoporotic hip fracture in an Asian population. Bone. 2016;83:171–7. https://doi.org/10.1016/j.bone.2015.11.005.CrossRefPubMed

94.

Tamaki J, Iki M, Kadowaki E, Sato Y, Chiba Y, Akiba T, et al. Biochemical markers for bone turnover predict risk of vertebral fractures in postmenopausal women over 10 years: the Japanese Population-based Osteoporosis (JPOS) Cohort Study. Osteoporos Int. 2013;24(3):887–97. https://doi.org/10.1007/s00198-012-2106-7.CrossRefPubMed

95.

Zhao J, Xia W, Nie M, Zheng X, Wang Q, Wang X, et al. The levels of bone turnover markers in Chinese postmenopausal women: Peking Vertebral Fracture study. Menopause. 2011;18(11):1237–43. https://doi.org/10.1097/gme.0b013e31821d7ff7.CrossRefPubMed

96.

Sowers MR, Zheng H, Greendale GA, Neer RM, Cauley JA, Ellis J, et al. Changes in bone resorption across the menopause transition: effects of reproductive hormones, body size, and ethnicity. J Clin Endocrinol Metab. 2013;98(7):2854–63. https://doi.org/10.1210/jc.2012-4113.CrossRefPubMedPubMedCentral

97.

Sowers MR, Greendale GA, Bondarenko I, Finkelstein JS, Cauley JA, Neer RM, et al. Endogenous hormones and bone turnover markers in pre- and perimenopausal women: SWAN. Osteoporos Int. 2003;14(3):191–7. https://doi.org/10.1007/s00198-002-1329-4.CrossRefPubMed

98.

Finkelstein JS, Sowers M, Greendale GA, Lee ML, Neer RM, Cauley JA, et al. Ethnic variation in bone turnover in pre- and early perimenopausal women: effects of anthropometric and lifestyle factors. J Clin Endocrinol Metab. 2002;87(7):3051–6. https://doi.org/10.1210/jcem.87.7.8480.CrossRefPubMed

99.

Arasu A, Cawthon PM, Lui LY, Do TP, Arora PS, Cauley JA, et al. Serum sclerostin and risk of hip fracture in older Caucasian women. J Clin Endocrinol Metab. 2012;97(6):2027–32. https://doi.org/10.1210/jc.2011-3419.CrossRefPubMedPubMedCentral

100.

Costa AG, Walker MD, Zhang CA, Cremers S, Dworakowski E, McMahon DJ, et al. Circulating sclerostin levels and markers of bone turnover in Chinese-American and white women. J Clin Endocrinol Metab. 2013;98(12):4736–43. https://doi.org/10.1210/jc.2013-2106.CrossRefPubMedPubMedCentral

101.

Silverman SL, Madison RE. Decreased incidence of hip fracture in Hispanics, Asians, and blacks: California Hospital Discharge Data. Am J Public Health. 1988;78(11):1482–3. https://doi.org/10.2105/ajph.78.11.1482.CrossRefPubMedPubMedCentral

102.

Zingmond DS, Melton LJ 3rd, Silverman SL. Increasing hip fracture incidence in California Hispanics, 1983 to 2000. Osteoporos Int. 2004;15(8):603–10. https://doi.org/10.1007/s00198-004-1592-7.CrossRefPubMed

103.

Lo JC, Zheng P, Grimsrud CD, Chandra M, Ettinger B, Budayr A, et al. Racial/ethnic differences in hip and diaphyseal femur fractures. Osteoporos Int. 2014;25(9):2313–8. https://doi.org/10.1007/s00198-014-2750-1.CrossRefPubMed

104.

Gordon NP, Lin TY, Rau J, Lo JC. Aggregation of Asian-American subgroups masks meaningful differences in health and health risks among Asian ethnicities: an electronic health record based cohort study. BMC Public Health. 2019;19(1):1551. https://doi.org/10.1186/s12889-019-7683-3.CrossRefPubMedPubMedCentral

105.

Shah NS, Luncheon C, Kandula NR, Khan SS, Pan L, Gillespie C, et al. Heterogeneity in obesity prevalence among Asian American adults. Ann Intern Med. 2022;175(11):1493–500. https://doi.org/10.7326/M22-0609.CrossRefPubMedPubMedCentral

106.

Geng Y, Lo JC, Brickner L, Gordon NP. Racial-ethnic differences in fall prevalence among older women: a cross-sectional survey study. BMC Geriatr. 2017;17(1):65. https://doi.org/10.1186/s12877-017-0447-y.CrossRefPubMedPubMedCentral

107.

Cauley JA, Wu L, Wampler NS, Barnhart JM, Allison M, Chen Z, et al. Clinical risk factors for fractures in multi-ethnic women: the Women’s Health Initiative. J Bone Miner Res. 2007;22(11):1816–26. https://doi.org/10.1359/jbmr.070713.CrossRefPubMed

108.

Ballane G, Cauley JA, Luckey MM, El-Hajj FG. Worldwide prevalence and incidence of osteoporotic vertebral fractures. Osteoporos Int. 2017;28(5):1531–42. https://doi.org/10.1007/s00198-017-3909-3.CrossRefPubMed

109.

Xia W, Liu Q, Lv J, Zhang Z, Wu W, Xie Z, et al. Prevalent vertebral fractures among urban-dwelling Chinese postmenopausal women: a population-based, randomized-sampling, cross-sectional study. Arch Osteoporos. 2022;17(1):120. https://doi.org/10.1007/s11657-022-01158-x.CrossRefPubMedPubMedCentral

110.

Bow CH, Cheung E, Cheung CL, Xiao SM, Loong C, Soong C, et al. Ethnic difference of clinical vertebral fracture risk. Osteoporos Int. 2012;23(3):879–85. https://doi.org/10.1007/s00198-011-1627-9.CrossRefPubMed

111.

Shane E, Burr D, Abrahamsen B, Adler RA, Brown TD, Cheung AM, et al. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a Task Force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2014;29(1):1–23. https://doi.org/10.1002/jbmr.1998.CrossRefPubMed

112.

Ettinger B, Burr DB, Ritchie RO. Proposed pathogenesis for atypical femoral fractures: Lessons from material research. Bone. 2013;55(2):495–500. https://doi.org/10.1016/j.bone.2013.02.004.CrossRefPubMed

113.

Lo JC, Grimsrud CD, Ott SM, Chandra M, Hui RL, Ettinger B. Atypical femur fracture incidence in women increases with duration of bisphosphonate exposure. Osteoporos Int. 2019;30(12):2515–20. https://doi.org/10.1007/s00198-019-05112-5.CrossRefPubMedPubMedCentral

114.

Lo JC, Neugebauer RS, Ettinger B, Chandra M, Hui RL, Ott SM, et al. Risk of complete atypical femur fracture with oral bisphosphonate exposure beyond three years. BMC Musculoskelet Disord. 2020;21(1):801. https://doi.org/10.1186/s12891-020-03672-w.CrossRefPubMedPubMedCentral

115.

Dell RM, Adams AL, Greene DF, Funahashi TT, Silverman SL, Eisemon EO, et al. Incidence of atypical nontraumatic diaphyseal fractures of the femur. J Bone Miner Res. 2012;27(12):2544–50. https://doi.org/10.1002/jbmr.1719.CrossRefPubMed

116.

Schilcher J, Koeppen V, Aspenberg P, Michaelsson K. Risk of atypical femoral fracture during and after bisphosphonate use. Acta Orthop. 2015;86(1):100–7. https://doi.org/10.3109/17453674.2015.1004149.CrossRefPubMedPubMedCentral

117.

Kim JW, Kim JJ, Byun YS, Shon OJ, Oh HK, Park KC, et al. Factors affecting fracture location in atypical femoral fractures: A cross-sectional study with 147 patients. Injury. 2017;48(7):1570–4. https://doi.org/10.1016/j.injury.2017.05.033.CrossRefPubMed

118.

Chen LP, Chang TK, Huang TY, Kwok TG, Lu YC. The correlation between lateral bowing angle of the femur and the location of atypical femur fractures. Calcif Tissue Int. 2014;95(3):240–7. https://doi.org/10.1007/s00223-014-9887-y.CrossRefPubMed

119.

Koh JS, Goh SK, Png MA, Ng AC, Howe TS. Distribution of atypical fractures and cortical stress lesions in the femur: implications on pathophysiology. Singapore Med J. 2011;52(2):77–80.PubMed

120.

Ng AC, Png MA, Chua DT, Koh JS, Howe TS. Review: Epidemiology and Pathophysiology of Atypical Femur Fractures. Curr Osteoporos Rep. 2014;12(1):65–73. https://doi.org/10.1007/s11914-014-0198-z.CrossRefPubMed

121.

Taormina DP, Marcano AI, Karia R, Egol KA, Tejwani NC. Symptomatic atypical femoral fractures are related to underlying hip geometry. Bone. 2014;63:1–6. https://doi.org/10.1016/j.bone.2014.02.006.CrossRefPubMed

122.

Haider IT, Schneider PS, Edwards WB. The role of lower-limb geometry in the pathophysiology of atypical femoral fracture. Curr Osteoporos Rep. 2019;17(5):281–90. https://doi.org/10.1007/s11914-019-00525-x.CrossRefPubMed

123.

• Dhanekula ND, Crouch G, Byth K, Lau SL, Kim A, Graham E, et al. Asian ethnicity and femoral geometry in atypical femur fractures: Independent or interdependent risk factors? JBMR Plus. 2022;6(4):e10607. https://doi.org/10.1002/jbm4.10607. This Australian study examines femur geometry in women with atypical or typical femur fracture and identifies Asian ethnicity as a strong predictor of atypical femur fracture, independent of hip geometry.CrossRefPubMedPubMedCentral

124.

Black DM, Abrahamsen B, Bouxsein ML, Einhorn T, Napoli N. Atypical femur fractures: review of epidemiology, relationship to bisphosphonates, prevention, and clinical management. Endocr Rev. 2019;40(2):333–68. https://doi.org/10.1210/er.2018-00001.CrossRefPubMed

125.

Zhou W, van Rooij JGJ, Ebeling PR, Verkerk A, Zillikens MC. The genetics of atypical femur fractures – a systematic review. Curr Osteoporos Rep. 2021;19(2):123–30. https://doi.org/10.1007/s11914-021-00658-y.CrossRefPubMedPubMedCentral

126.

Ott SM, Heckbert SR. Atypical femur fracture risk versus fragility fracture prevention with bisphosphonates. N Engl J Med. 2020;383(22):2188–9. https://doi.org/10.1056/NEJMc2029828.CrossRefPubMed

127.

Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet. 1996;348(9041):1535–41. https://doi.org/10.1016/s0140-6736(96)07088-2.CrossRefPubMed

128.

Cummings SR, Black DM, Thompson DE, Applegate WB, Barrett-Connor E, Musliner TA, et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA. 1998;280(24):2077–82. https://doi.org/10.1001/jama.280.24.2077.CrossRefPubMed

129.

McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C, et al. Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med. 2001;344(5):333–40. https://doi.org/10.1056/NEJM200102013440503.CrossRefPubMed

130.

Lyles KW, Colon-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C, et al. Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med. 2007;357(18):1799–809. https://doi.org/10.1056/NEJMoa074941.CrossRefPubMed

131.

Dawson-Hughes B, Tosteson AN, Melton LJ 3rd, Baim S, Favus MJ, Khosla S, et al. Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporos Int. 2008;19(4):449–58. https://doi.org/10.1007/s00198-008-0559-5.CrossRefPubMed

132.

• Leslie WD, Morin SN, Lix LM, McCloskey EV, Johansson H, Harvey NC, et al. Fracture prediction from FRAX for Canadian ethnic groups: a registry-based cohort study. Osteoporos Int. 2021;32(1):113–22. https://doi.org/10.1007/s00198-020-05594-8. This study demonstrates the overestimation of fracture risk in Canadian Asian and Black women when the Canadian FRAX calculator is used. Overestimation is reduced with US ethnic FRAX calculators.CrossRefPubMed

133.

Lewiecki EM, Wright NC, Singer AJ. Racial disparities, FRAX, and the care of patients with osteoporosis. Osteoporos Int. 2020;31(11):2069–71. https://doi.org/10.1007/s00198-020-05655-y.CrossRefPubMedPubMedCentral

134.

Kanis JA, Johansson H, Harvey NC, McCloskey EV. A brief history of FRAX. Arch Osteoporos. 2018;13(1):118. https://doi.org/10.1007/s11657-018-0510-0.CrossRefPubMedPubMedCentral

135.

Kanis JA, Harvey NC, Johansson H, Oden A, Leslie WD, McCloskey EV. FRAX update. J Clin Densitom. 2017;20(3):360–7. https://doi.org/10.1016/j.jocd.2017.06.022.CrossRefPubMed

136.

Wu JY. Considering race and ethnicity in the management of bone health. J Bone Miner Res. 2021;36(10):1879–80. https://doi.org/10.1002/jbmr.4437.CrossRefPubMed

137.

Morin SN, Berger C, Papaioannou A, Cheung AM, Rahme E, Leslie WD, et al. Race/ethnic differences in the prevalence of osteoporosis, falls and fractures: a cross-sectional analysis of the Canadian Longitudinal Study on Aging. Osteoporos Int. 2022;33(12):2637–48. https://doi.org/10.1007/s00198-022-06539-z.CrossRefPubMed

138.

Fujiwara S, Huang C, Ross PD, Yamada M, Kodama K, Davis JW, et al. Differences in health characteristics between native Japanese and Japanese-Americans. J Cross Cult Gerontol. 1999;14(3):273–87. https://doi.org/10.1023/a:1006627908855.CrossRefPubMed

139.

Ferrari SL, Abrahamsen B, Napoli N, Akesson K, Chandran M, Eastell R, et al. Diagnosis and management of bone fragility in diabetes: an emerging challenge. Osteoporos Int. 2018;29(12):2585–96. https://doi.org/10.1007/s00198-018-4650-2.CrossRefPubMedPubMedCentral

140.

Leslie WD, Johansson H, McCloskey EV, Harvey NC, Kanis JA, Hans D. Comparison of methods for improving fracture risk assessment in diabetes: The Manitoba BMD Registry. J Bone Miner Res. 2018;33(11):1923–30. https://doi.org/10.1002/jbmr.3538.CrossRefPubMed

141.

•• Vandenput L, Johansson H, McCloskey EV, Liu E, Akesson KE, Anderson FA, et al. Update of the fracture risk prediction tool FRAX: a systematic review of potential cohorts and analysis plan. Osteoporos Int. 2022;33(10):2103–36. https://doi.org/10.1007/s00198-022-06435-6. This important report describes plans to assemble international cohorts with prospective data on incident fracture outcomes and baseline risk factors to inform an updated FRAX tool. Ethnicity-specific risk will also be examined.CrossRefPubMed

142.

Kuruvilla K, Kenny AM, Raisz LG, Kerstetter JE, Feinn RS, Rajan TV. Importance of bone mineral density measurements in evaluating fragility bone fracture risk in Asian Indian men. Osteoporos Int. 2011;22(1):217–21. https://doi.org/10.1007/s00198-010-1237-y.CrossRefPubMed

143.

Johansson H, Oden A, Lorentzon M, McCloskey E, Kanis JA, Harvey NC, et al. Is the Swedish FRAX model appropriate for Swedish immigrants? Osteoporos Int. 2015;26(11):2617–22. https://doi.org/10.1007/s00198-015-3180-4.CrossRefPubMed

144.

McCloskey EV, Harvey NC, Johansson H, Kanis JA. FRAX updates 2016. Curr Opin Rheumatol. 2016;28(4):433–41. https://doi.org/10.1097/BOR.0000000000000304.CrossRefPubMed

145.

Lo JC, Nath S, Patel M, Chandra M, Yang B, Weintraub MR, et al. Variation in fracture risk estimation among East Asian women. Am J Manag Care. 2021;27(3):e97–100. https://doi.org/10.37765/ajmc.2021.88604.CrossRefPubMed

146.

Chan DC, McCloskey EV, Chang CB, Lin KP, Lim LC, Tsai KS, et al. Establishing and evaluating FRAX probability thresholds in Taiwan. J Formos Med Assoc. 2017;116(3):161–8. https://doi.org/10.1016/j.jfma.2016.03.006.CrossRefPubMed

147.

Cauley JA, Chalhoub D, Kassem AM, Fuleihan GH. Geographic and ethnic disparities in osteoporotic fractures. Nat Rev Endocrinol. 2014;10(6):338–51. https://doi.org/10.1038/nrendo.2014.51.CrossRefPubMed

148.

Megyesi MS, Hunt LM, Brody H. A critical review of racial/ethnic variables in osteoporosis and bone density research. Osteoporos Int. 2011;22(6):1669–79. https://doi.org/10.1007/s00198-010-1503-z.CrossRefPubMed

149.

Leslie WD. Clinical review: ethnic differences in bone mass–clinical implications. J Clin Endocrinol Metab. 2012;97(12):4329–40. https://doi.org/10.1210/jc.2012-2863.CrossRefPubMed

150.

Rose VL. NOF urges bone density tests for certain postmenopausal women and all women over age 65. Am Fam Physician. 1999;59(4):1047 (51).PubMed

151.

Osteoporosis Screening in Older Women (OSW). HEDIS Measures and Technical Resources. National Committee for Quality Assurance, 2023. https://www.ncqa.org/hedis/measures/osteoporosis-screening-in-older-women/. Accessed 25 May 2023.

152.

Bala Y, Depalle B, Farlay D, Douillard T, Meille S, Follet H, et al. Bone micromechanical properties are compromised during long-term alendronate therapy independently of mineralization. J Bone Miner Res. 2012;27(4):825–34. https://doi.org/10.1002/jbmr.1501.CrossRefPubMed

153.

Ott SM. Consider the bisphosphonate dose. J Bone Miner Res. 2022;37(1):1–2. https://doi.org/10.1002/jbmr.4479.CrossRefPubMed

154.

Adler RA, El-Hajj Fuleihan G, Bauer DC, Camacho PM, Clarke BL, Clines GA, et al. Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a task force of the American society for bone and mineral research. J Bone Miner Res. 2016;31(10):1910. https://doi.org/10.1002/jbmr.2918.CrossRefPubMed

155.

Orimo H, Nakamura T, Hosoi T, Iki M, Uenishi K, Endo N, et al. Japanese 2011 guidelines for prevention and treatment of osteoporosis–executive summary. Arch Osteoporos. 2012;7(1–2):3–20. https://doi.org/10.1007/s11657-012-0109-9.CrossRefPubMedPubMedCentral

156.

•• Reid IR, Horne AM, Mihov B, Stewart A, Garratt E, Wong S, et al. Fracture prevention with zoledronate in older women with osteopenia. N Engl J Med. 2018;379(25):2407–16. https://doi.org/10.1056/NEJMoa1808082. This randomized trial compared four 18-month infusions of zoledronate to placebo among women aged ≥65 years with osteopenia and found that the risk of nonvertebral or vertebral fracture was much lower in the zoledronate group.CrossRefPubMed

157.

•• Grey A, Bolland MJ, Horne A, Mihov B, Gamble G, Reid IR. Bone mineral density and bone turnover 10 years after a single 5 mg dose or two 5-yearly lower doses of zoledronate in osteopenic older women: an open-label extension of a randomized controlled trial. J Bone Miner Res. 2022;37(1):3–11. https://doi.org/10.1002/jbmr.4453. This open label extension study reported higher bone mineral density and lower bone resorption marker levels at 9-10 years following a single 5 mg dose of zoledronate or two 2.5 mg doses given at 5 year intervals.

Titel: Osteoporosis and Fracture Risk among Older US Asian Adults
verfasst von: Joan C. Lo
Wei Yang
Jennifer J. Park-Sigal
Susan M. Ott
Publikationsdatum: 05.08.2023
Verlag: Springer US
Erschienen in: Current Osteoporosis Reports / Ausgabe 5/2023
Print ISSN: 1544-1873
Elektronische ISSN: 1544-2241
DOI: https://doi.org/10.1007/s11914-023-00805-7

Defects in Bone and Bone Marrow in Inherited Anemias: the Chicken or the Egg

Recommendations for High-resolution Peripheral Quantitative Computed Tomography Assessment of Bone Density, Microarchitecture, and Strength in Pediatric Populations

Open Access

Role of the Peripheral Nervous System in Skeletal Development and Regeneration: Controversies and Clinical Implications

Open Access

Cranial Neural Crest Cells Contribution to Craniofacial Bone Development and Regeneration

Mitochondrial Genetics and Function as Determinants of Bone Phenotype and Aging

Fracture Risk in Patients with Hypoparathyroidism

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie erweitert durch Fallbeispiele, Videos und Abbildungen. Zur Fortbildung und Wissenserweiterung, verfasst und geprüft von Expertinnen und Experten der Gesellschaft für Arthroskopie und Gelenkchirurgie (AGA).

Jetzt entdecken!

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Nackenschmerzen nach Bandscheibenvorfall: Muskeltraining hilft!

15.01.2025
Nackenschmerzen
Nachrichten

Bei hartnäckigen Schmerzen aufgrund einer zervikalen Radikulopathie schlägt ein Team der Universität Istanbul vor, lokale Steroidinjektionen mit einem speziellen Trainingsprogramm zur Stabilisierung der Nackenmuskulatur zu kombinieren.

Die elektronische Patientenakte kommt: Das sollten Sie jetzt wissen

12.01.2025
Elektronische Patientenakte
Nachrichten

Am 15. Januar geht die „ePA für alle“ zunächst in den Modellregionen an den Start. Doch schon bald soll sie in allen Praxen zum Einsatz kommen. Was ist jetzt zu tun? Was müssen Sie wissen? Wir geben in einem FAQ Antworten auf 21 Fragen.

Was sich Menschen mit Frozen Shoulder wünschen

10.01.2025
Schultersteife
Nachrichten

Die Capsulitis adhaesiva des Glenohumeralgelenks, auch als Frozen Shoulder bezeichnet, belastet die Betroffenen weit über die körperlichen Beschwerden hinaus, wie eine italienische Studie ergeben hat.

Restriktive Sauerstoffgabe ohne Vorteil bei schwerem Trauma

09.01.2025
Traumatologische Notfallmedizin
Nachrichten

Ob schwer verletzte Personen besser restriktiv oder liberal mit Sauerstoff versorgt werden sollten, hat die Arbeitsgruppe der TRAUMOX2-Studie untersucht – mit klarem Ergebnis.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Osteoporosis and Fracture Risk among Older US Asian Adults

Abstract

Purpose of Review

Recent Findings

Summary

Weitere Artikel der Ausgabe 5/2023

Defects in Bone and Bone Marrow in Inherited Anemias: the Chicken or the Egg

Recommendations for High-resolution Peripheral Quantitative Computed Tomography Assessment of Bone Density, Microarchitecture, and Strength in Pediatric Populations

Role of the Peripheral Nervous System in Skeletal Development and Regeneration: Controversies and Clinical Implications

Cranial Neural Crest Cells Contribution to Craniofacial Bone Development and Regeneration

Mitochondrial Genetics and Function as Determinants of Bone Phenotype and Aging

Fracture Risk in Patients with Hypoparathyroidism

Arthropedia

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Nackenschmerzen nach Bandscheibenvorfall: Muskeltraining hilft!

Die elektronische Patientenakte kommt: Das sollten Sie jetzt wissen

Was sich Menschen mit Frozen Shoulder wünschen

Restriktive Sauerstoffgabe ohne Vorteil bei schwerem Trauma

Update Orthopädie und Unfallchirurgie

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten